Kojima et al., 1992 - Google Patents
Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells.Kojima et al., 1992
View PDF- Document ID
- 4989791340353446893
- Author
- Kojima T
- Leone C
- Marchildon G
- Marcum J
- Rosenberg R
- Publication year
- Publication venue
- Journal of Biological Chemistry
External Links
Snippet
We have isolated heparan sulfate proteoglycans (HSPGs) from cloned rat microvascular endothelial cells using a combination of ion-exchange chromatography, affinity fractionation with antithrombin III (AT III), and gel filtration in denaturing solvents. The anticoagulantly …
- 102000008055 Heparan Sulfate Proteoglycans 0 title abstract description 142
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kojima et al. | Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells. | |
Marcum et al. | Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. | |
Bourin et al. | Isolation and characterization of the glycosaminoglycan component of rabbit thrombomodulin proteoglycan. | |
Rosenberg et al. | Correlation between structure and function of heparin | |
Rosenberg et al. | Structure-function relationships of heparin species | |
Fritze et al. | An antiproliferative heparan sulfate species produced by postconfluent smooth muscle cells. | |
Thunberg et al. | Further characterization of the antithrombin-binding sequence in heparin | |
Lyon et al. | Liver heparan sulfate structure. A novel molecular design | |
Rosenberg | Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism | |
Bach et al. | The defect in the Hunter syndrome: deficiency of sulfoiduronate sulfatase | |
Griffin et al. | Isolation and characterization of heparan sulfate from crude porcine intestinal mucosal peptidoglycan heparin | |
Oldberg et al. | Characterization of platelet endoglycosidase degrading heparin-like polysaccharides | |
Hook et al. | Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin | |
Pejler et al. | Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides. | |
Riesenfeld et al. | The antithrombin-binding sequence of heparin. Location of essential N-sulfate groups. | |
Winterbourne et al. | Cells selected for high tumorigenicity or transformed by simian virus 40 synthesize heparan sulfate with reduced degree of sulfation. | |
Wright et al. | Structural determinants of heparin's growth inhibitory activity: interdependence of oligosaccharide size and charge | |
IE51166B1 (en) | Oligosaccharides and oligosaccharide fractions having biological properties,processes for obtaining them and pharmaceutical compositions containing them | |
Uhlin-Hansen et al. | Differential effect of brefeldin A on the biosynthesis of heparan sulfate and chondroitin/dermatan sulfate proteoglycans in rat ovarian granulosa cells in culture | |
Damm et al. | Separation of natural and synthetic heparin fragments by high-performance capillary electrophoresis | |
Midura et al. | Analysis of the proteoglycans synthesized by corneal explants from embryonic chicken: II. Structural characterization of the keratan sulfate and dermatan sulfate proteoglycans from corneal stroma | |
Fransson et al. | Proteoheparan sulfate from human skin fibroblasts. Evidence for self-interaction via the heparan sulfate side chains. | |
Ellis et al. | The relative molecular mass dependence of the anti-factor Xa properties of heparin | |
Bame et al. | Coupling of N-deacetylation and N-sulfation in a Chinese hamster ovary cell mutant defective in heparan sulfate N-sulfotransferase | |
Yaoita et al. | Isolation and characterization of proteoglycans synthesized by cultured mesangial cells. |